Apeiron Biologics has been cleared to start a European phase 2 trial of a drug that it says could stop COVID-19 entering cells, blocking the infection.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,